CompletedNCT05839041
A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
PHASE2 · 300 planned enrolment
- Countries listed
- 1
- Registry update
- September 16, 2026
immortal.lifeExact source-linked program identifier and related public trial registrations.
1 exact source-linked registration. No aliases, synonyms, ownership, or cross-source equivalence are inferred.
PHASE2 · 300 planned enrolment